Pharmaceutical Sterility Testing Market: by Sample (Sterile Drugs, Medical Devices, and Biologics), by Product Type (Instruments, Kits & Reagents, and Services), by Type (In-house and Outsourcing), by Test Type (Sterility Testing, Bioburden Testing, and Bacterial Endotoxin Testing), by End User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast to 2030
Market Overview
Fatpos Global has released a report titled
Pharmaceutical Sterility Testing Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According to a study by Fatpos Global, is anticipated to reach USD 1,285.8 million by 2030 at a CAGR of 6.6%.. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Pharmaceutical Sterility Testing Market Market: Key Players
Merck KGaA (Germany)
Rapid Micro Biosystems (US)
Sartorius AG (Germany)
Solvias AG (Switzerland)
SGS SA (Switzerland)
Boston Analytical (US)
BioM?rieux, Inc. (France)
Charles River Laboratories International, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pace Analytical Services, LLC (US)
Toxikon, Inc. (US)
Sotera Health (US)
Pacific Biolabs Inc. (US)
STRERIS Corporation (US)
WuXi AppTec (China)
Recent Developments
In August 2020, Pace Analytical Services, LLC acquired Emerson Resources Inc. (US), a contract production and manufacturing organization (CDMO). The acquisition will enable the company to service pharmaceutical and biopharmaceutical industries from early-stage product development to phase II clinical trial material manufacturing.
In May 2020, Suez S.A. launched the Sievers Eclipse Bacterial Endotoxin Testing platform, which saves pipetting processes, lowers operator-to-operator variability, and boosts laboratory productivity.
In October 2019, Alcami Corporation launched a new rapid sterility offering, a service that uses cutting-edge microbiological testing technology to provide consumers with much faster testing results.
In August 2018, Sotera Health acquired Gibraltar Laboratories (US). The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health's Nelson Labs.
Segmentation
Scope of the Report & Segmentation
By Sample
Sterile Drugs
Medical Devices
Biologics
By Product Type
Instruments
Kits & Reagents
Services
By Type
In-house
Outsourcing
By Product Type
Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing
By End User
Compounding Pharmacies
Medical Devices Companies
Pharmaceutical Companies
Others
Pharmaceutical Sterility Testing Market Market Dynamics
Pharmaceutical Sterility Testing Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the
Pharmaceutical Sterility Testing Market Market growth?
Which segment accounted for the largest
Pharmaceutical Sterility Testing Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Fatpos Global has released a report titled
Pharmaceutical Sterility Testing Market - Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2031. According to a study by Fatpos Global, is anticipated to reach USD 1,285.8 million by 2030 at a CAGR of 6.6%.. According to the report, emphasizes on the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry and CAGR in order to provide a comprehensive outlook of the global market
Pharmaceutical Sterility Testing Market Market: Key Players
Merck KGaA (Germany)
Rapid Micro Biosystems (US)
Sartorius AG (Germany)
Solvias AG (Switzerland)
SGS SA (Switzerland)
Boston Analytical (US)
BioM?rieux, Inc. (France)
Charles River Laboratories International, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pace Analytical Services, LLC (US)
Toxikon, Inc. (US)
Sotera Health (US)
Pacific Biolabs Inc. (US)
STRERIS Corporation (US)
WuXi AppTec (China)
Recent Developments
In August 2020, Pace Analytical Services, LLC acquired Emerson Resources Inc. (US), a contract production and manufacturing organization (CDMO). The acquisition will enable the company to service pharmaceutical and biopharmaceutical industries from early-stage product development to phase II clinical trial material manufacturing.
In May 2020, Suez S.A. launched the Sievers Eclipse Bacterial Endotoxin Testing platform, which saves pipetting processes, lowers operator-to-operator variability, and boosts laboratory productivity.
In October 2019, Alcami Corporation launched a new rapid sterility offering, a service that uses cutting-edge microbiological testing technology to provide consumers with much faster testing results.
In August 2018, Sotera Health acquired Gibraltar Laboratories (US). The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health's Nelson Labs.
Segmentation
Scope of the Report & Segmentation
By Sample
Sterile Drugs
Medical Devices
Biologics
By Product Type
Instruments
Kits & Reagents
Services
By Type
In-house
Outsourcing
By Product Type
Sterility Testing
Bioburden Testing
Bacterial Endotoxin Testing
By End User
Compounding Pharmacies
Medical Devices Companies
Pharmaceutical Companies
Others
Pharmaceutical Sterility Testing Market Market Dynamics
Pharmaceutical Sterility Testing Market Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the
Pharmaceutical Sterility Testing Market Market growth?
Which segment accounted for the largest
Pharmaceutical Sterility Testing Market Market share?
Who are the key players in the Griddles Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
1. EXECUTIVE SUMMARY
2.
Pharmaceutical Sterility Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10.
Pharmaceutical Sterility Testing Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11.
Pharmaceutical Sterility Testing Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.
Pharmaceutical Sterility Testing Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Merck KGaA (Germany)
Rapid Micro Biosystems (US)
Sartorius AG (Germany)
Solvias AG (Switzerland)
SGS SA (Switzerland)
Boston Analytical (US)
BioM?rieux, Inc. (France)
Charles River Laboratories International, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pace Analytical Services, LLC (US)
Toxikon, Inc. (US)
Sotera Health (US)
Pacific Biolabs Inc. (US)
STRERIS Corporation (US)
WuXi AppTec (China)
Recent Developments
In August 2020, Pace Analytical Services, LLC acquired Emerson Resources Inc. (US), a contract production and manufacturing organization (CDMO). The acquisition will enable the company to service pharmaceutical and biopharmaceutical industries from early-stage product development to phase II clinical trial material manufacturing.
In May 2020, Suez S.A. launched the Sievers Eclipse Bacterial Endotoxin Testing platform, which saves pipetting processes, lowers operator-to-operator variability, and boosts laboratory productivity.
In October 2019, Alcami Corporation launched a new rapid sterility offering, a service that uses cutting-edge microbiological testing technology to provide consumers with much faster testing results.
In August 2018, Sotera Health acquired Gibraltar Laboratories (US). The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health's Nelson Labs.
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2.
Pharmaceutical Sterility Testing Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10.
Pharmaceutical Sterility Testing Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11.
Pharmaceutical Sterility Testing Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.
Pharmaceutical Sterility Testing Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By network type: Market Share (2020-2030F)
12.2.1. Hardware , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Software , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.3. Services , By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By End user: Market Share (2020-2030F)
12.3.1. Manufacturing, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Healthcare, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Energy and Utilities, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. IT & Telecom, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Automotive and Transportation, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Supply Chain and Logistics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Government and Public Safety, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Agriculture, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.9. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
Merck KGaA (Germany)
Rapid Micro Biosystems (US)
Sartorius AG (Germany)
Solvias AG (Switzerland)
SGS SA (Switzerland)
Boston Analytical (US)
BioM?rieux, Inc. (France)
Charles River Laboratories International, Inc. (US)
Thermo Fisher Scientific, Inc. (US)
Pace Analytical Services, LLC (US)
Toxikon, Inc. (US)
Sotera Health (US)
Pacific Biolabs Inc. (US)
STRERIS Corporation (US)
WuXi AppTec (China)
Recent Developments
In August 2020, Pace Analytical Services, LLC acquired Emerson Resources Inc. (US), a contract production and manufacturing organization (CDMO). The acquisition will enable the company to service pharmaceutical and biopharmaceutical industries from early-stage product development to phase II clinical trial material manufacturing.
In May 2020, Suez S.A. launched the Sievers Eclipse Bacterial Endotoxin Testing platform, which saves pipetting processes, lowers operator-to-operator variability, and boosts laboratory productivity.
In October 2019, Alcami Corporation launched a new rapid sterility offering, a service that uses cutting-edge microbiological testing technology to provide consumers with much faster testing results.
In August 2018, Sotera Health acquired Gibraltar Laboratories (US). The acquisition is expected to expand the business of analytical testing capabilities of Sotera Health's Nelson Labs.
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
